List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 926 studies with search of: "Ovarian Neoplasms"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Ovarian Cancer
Interventions: Drug: AZD0530;   Drug: Carboplatin;   Drug: Paclitaxel
2 Recruiting MK4827 in Patients With Advanced Solid Tumors and BRCA Mutant Ovarian Cancer
Conditions: Solid Tumors and Ovarian Neoplasms;   Ovarian Neoplasms
Intervention: Drug: Comparator: MK4827 (PARP inhibitor)
3 Recruiting A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer
Conditions: Carcinoma;   Ovarian Cancer;   Ovarian Diseases;   Ovarian Neoplasms
Intervention: Biological: AGS-8M4
4 Recruiting A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer
Conditions: Carcinoma;   Ovarian Cancer;   Ovarian Diseases;   Ovarian Neoplasms
Interventions: Biological: AGS-8M4;   Drug: Pegylated liposomal doxorubicin (PLD);   Drug: gemcitabine;   Drug: carboplatin
5 Active, not recruiting Phase II Study of the Trifunctional Antibody Catumaxomab Administered Intra- and Postoperatively in Patients With Ovarian Cancer
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer
Intervention: Drug: Catumaxomab
6 Recruiting Study of Individuals and Families at High Risk for Breast or Ovarian Cancer
Conditions: Breast Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer
Interventions: Genetic: gene mapping;   Genetic: mutation analysis;   Other: questionnaire administration;   Procedure: biopsy;   Procedure: breast duct lavage;   Procedure: breast imaging study;   Procedure: magnetic resonance imaging;   Procedure: radiomammography;   Procedure: study of high risk factors
7 Recruiting Ovarian Cancer Early Detection Program Screening Study
Conditions: Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer
Interventions: Genetic: chromosomal translocation analysis;   Genetic: comparative genomic hybridization;   Genetic: microsatellite instability analysis;   Genetic: mutation analysis;   Genetic: polymorphic microsatellite marker analysis;   Other: cytology specimen collection procedure;   Other: laboratory biomarker analysis;   Other: ovarian Papanicolaou test;   Procedure: laparoscopy;   Procedure: study of high risk factors
8 Recruiting AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or Ovarian Epithelial Cancer
Conditions: brca1 Mutation Carrier;   brca2 Mutation Carrier;   Breast Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer
Interventions: Drug: carboplatin;   Drug: olaparib;   Genetic: polymorphism analysis;   Other: enzyme-linked immunosorbent assay;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies
9 Completed ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: SH-Y03757A (ZK-Epothilone; ZK-219477) with carboplatin
10 Completed A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment
Conditions: Ovarian Cancer;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer
Interventions: Drug: belinostat;   Drug: Paclitaxel;   Drug: Carboplatin
11 Recruiting Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms
Condition: Ovarian Neoplasms
Intervention: Procedure: removal of ovarian vessels
12 Recruiting Study on the Benefit of Additional Intraperitoneal Chemotherapy in Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: IV PACLITAXEL+CARBOPLATIN PLUS IP PACLITAXEL
13 Recruiting Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial
Condition: Ovarian Neoplasms
Intervention: Procedure: neoadjuvant chemotherapy (Carboplatin/Docetaxel)
14 Completed Study of OSI-211 Vs. Topotecan in Patients With Relapsed Epithelial Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: OSI-211 (Liposomal Lurtotecan)
15 Completed Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites
Conditions: Ovarian Neoplasms;   Ascites
Interventions: Drug: aflibercept (AVE0005 / VEGF Trap);   Drug: placebo
16 Active, not recruiting Dose-finding Study Comparing Efficacy and Safety of a PARP Inhibitor Against Doxil in BRCA+ve Advanced Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: AZD2281;   Drug: Liposomal Doxorubicin
17 Terminated CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy
Condition: Ovarian Neoplasms
Interventions: Drug: CAELYX;   Drug: Paclitaxel HCl
18 Recruiting Microvascular Ultrasonographic Imaging for the Detection of Early Stage Epithelial Ovarian Carcinoma
Condition: Ovarian Neoplasms
Intervention:
19 Completed Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer
Condition: Ovarian Neoplasms
Intervention: Drug: docetaxel and cisplatin
20 Not yet recruiting Pharmacogenomics of Paclitaxel in Ovarian Cancer
Conditions: Ovarian Neoplasms;   Fallopian Tube Neoplasms
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services